LATEST RESEARCH

Research

Independent analysis of SEC filings, private funds, RIAs, websites and regulatory records.

MVP LS Fund DCLXXXVI Review 2026: $2M MicroVentures Vehicle, Private Secondary Access & SPV Structure Analysis
INDEPENDENT RESEARCH

MVP LS Fund DCLXXXVI Review 2026: $2M MicroVentures Vehicle, Private Secondary Access & SPV Structure Analysis

MVP LS FUND DCLXXXVI LLC is a verifiable September 2026 Delaware pooled investment vehicle connected to MicroVentures' long-running private-market investment infrastructure. Its September 18, 2026 Form D discloses a $2 million Rule 506(b) offering, with $0 sold at the time of the initial filing and the full $2 million

MicroVentures · CIK 0002131784Read article →
DVC Follow-up HF Review 2026: $1.73M SEC Filing, Davidovs Venture Collective & AI Follow-On Strategy Analysis
INDEPENDENT RESEARCH

DVC Follow-up HF Review 2026: $1.73M SEC Filing, Davidovs Venture Collective & AI Follow-On Strategy Analysis

DVC Follow-up HF, a series of Davidovs Advised Syndicate, LP, is a verifiable September 2026 pooled investment vehicle associated with the Davidovs Venture Collective ecosystem, but the most important finding is not the $1.73 million Form D itself. The real story is the way DVC has evolved from small, founder-led seed

Davidovs Venture Collective · CIK 0002127996Read article →
Marilla Capital-2 Review 2026: $35M One-Investor Reinsurance Vehicle, Aon Link & Bermuda Segregated Account Analysis
INDEPENDENT RESEARCH

Marilla Capital-2 Review 2026: $35M One-Investor Reinsurance Vehicle, Aon Link & Bermuda Segregated Account Analysis

Marilla Capital-2 is one of the more structurally distinctive private investment vehicles in this FilingDossier series because it is not a conventional hedge fund, venture fund or private equity partnership. It is a segregated account of Marilla Capital Ltd., a Bermuda exempted segregated accounts company, and its econ

Marilla · CIK 0002043656Read article →
Accumulator Liquidity I Review 2026: $3.25M Raised, 2 Investors, $148M RIA & Private-Tech Share-Swap Structure Analysis
INDEPENDENT RESEARCH

Accumulator Liquidity I Review 2026: $3.25M Raised, 2 Investors, $148M RIA & Private-Tech Share-Swap Structure Analysis

Accumulator Liquidity I LLC is a verifiable Delaware private investment vehicle inside a broader platform built around a highly differentiated private-market problem: founders and early shareholders often hold substantial wealth in illiquid private technology stock but do not want—or cannot easily arrange—a conventiona

Accumulator · CIK 0001947833Read article →
Sower Solas I Review 2026: $21M Lead Investment Into Solas Emerging Healthcare Fund, MedTech Portfolio & Double-Layer Fund Analysis
INDEPENDENT RESEARCH

Sower Solas I Review 2026: $21M Lead Investment Into Solas Emerging Healthcare Fund, MedTech Portfolio & Double-Layer Fund Analysis

Sower Solas I, L.P. is not a conventional standalone biotechnology venture fund. It is better understood as a specialized access vehicle created by Sower Investment Partners to invest into the Solas BioVentures Emerging Healthcare Fund. That distinction is the key to understanding the vehicle correctly.

Sower Investment Partners · CIK 0001944725Read article →
SW Florida Corp HQ Campus DST Review 2026: $167.34M 1031 Offering, Net Lease Capital Sponsor & Property-Identity Analysis
INDEPENDENT RESEARCH

SW Florida Corp HQ Campus DST Review 2026: $167.34M 1031 Offering, Net Lease Capital Sponsor & Property-Identity Analysis

SW Florida Corp HQ Campus DST is a newly launched 2026 Delaware Statutory Trust sponsored through the operating infrastructure of Net Lease Capital Advisors, one of the longer-established U.S. net-lease and 1031-exchange sponsors. The September 17, 2026 Form D reports a very large $167,340,578 offering, a $150,000 mini

Net Lease Capital Advisors · CIK 0002155232Read article →
Expect Equity Offshore Fund II Review 2026: $40M One-Investor Feeder, $47.8M Master Fund II & Emerging Manager Incubator Analysis
INDEPENDENT RESEARCH

Expect Equity Offshore Fund II Review 2026: $40M One-Investor Feeder, $47.8M Master Fund II & Emerging Manager Incubator Analysis

Expect Equity Offshore Fund II LP is a verifiable Cayman Islands hedge-fund vehicle with an unusually concentrated fundraising profile: its September 17, 2026 Form D/A reports $40 million sold to exactly one investor. The fund was formed in 2025, began selling interests on November 1, 2025, uses Rule 506(c), relies on

Expect Equity · CIK 0002085841Read article →
Verso Investment Partners II Review 2026: $10M First Investor, $521.6M RIA Platform & Hedge Fund Structure Analysis
INDEPENDENT RESEARCH

Verso Investment Partners II Review 2026: $10M First Investor, $521.6M RIA Platform & Hedge Fund Structure Analysis

Verso Investment Partners II, LP is a verifiable 2026 hedge fund managed by Verso Partners LP, an SEC-registered San Francisco investment adviser with approximately $521.6 million of regulatory assets under management as of its February 26, 2026 Form ADV. The September 17, 2026 Form D/A reports an indefinite Rule 506(b

Verso Partners · CIK 0002083166Read article →
CMT Digital Series 14 Review 2026: $2.3M Raised, 13 Investors & Crypto Co-Investment Structure Analysis
INDEPENDENT RESEARCH

CMT Digital Series 14 Review 2026: $2.3M Raised, 13 Investors & Crypto Co-Investment Structure Analysis

CMT Digital Investments I LLC - Series 14 is a verifiable 2026 venture capital vehicle tied directly to CMT Digital's Chicago-based digital-asset investment platform, and its structure is materially different from CMT Digital's flagship venture funds. The September 17, 2026 Form D reports an indefinite Rule 506(b) offe

CMT Digital · CIK 0002153167Read article →
Colossal Bio Opportunities Review 2026: $15M Offering, $2.2M Raised, 8 Investors & Colossal Biosciences Name-Link Analysis
INDEPENDENT RESEARCH

Colossal Bio Opportunities Review 2026: $15M Offering, $2.2M Raised, 8 Investors & Colossal Biosciences Name-Link Analysis

COLOSSAL BIO OPPORTUNITIES, LLC is a verifiable 2026 Delaware private offering, but the single most important finding is also the most cautionary: public evidence reviewed by FilingDossier does not yet establish that this vehicle is officially affiliated with, managed by, or invested in Colossal Biosciences. The Septem

Colossal Bio Opportunities · CIK 0002155938Read article →
NextGen Technology Fund I Review 2026: $600K Raised, 2 Investors, Tao Liu–Jian Sun Control Structure & Pontaq Name-Collision Analysis
INDEPENDENT RESEARCH

NextGen Technology Fund I Review 2026: $600K Raised, 2 Investors, Tao Liu–Jian Sun Control Structure & Pontaq Name-Collision Analysis

NextGen Technology Fund I LLC is a verifiable 2026 U.S. private investment vehicle, but it is also one of the clearest examples in this FilingDossier series of why name matching alone can produce a materially wrong company profile. The September 18, 2026 SEC Form D identifies the issuer as a Delaware limited liability

NextGen Technology Fund · CIK 0002155897Read article →
MFO Fund Review 2026: Mayfield-Linked Venture Vehicle, Navin Chaddha, $0 Initial Raise & Sand Hill Road Entity Analysis
INDEPENDENT RESEARCH

MFO Fund Review 2026: Mayfield-Linked Venture Vehicle, Navin Chaddha, $0 Initial Raise & Sand Hill Road Entity Analysis

MFO Fund, L.P. is a newly formed 2026 venture capital vehicle whose SEC filing provides unusually strong evidence linking it to Mayfield, one of Silicon Valley's longest-established venture firms, even though the issuer itself does not use the Mayfield name. The September 18, 2026 Form D identifies the fund as a Delawa

Mayfield · CIK 0002155144Read article →